900.08 Impact Of Active or Prior Cancer on Clinical Outcomes After TAVR: A Real-World Propensity-Matched Analysis
JACC: Cardiovascular Interventions · 2026-03 · 19 (5) · S63-S64
DOI: 10.1016/j.jcin.2026.01.218 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2026-03. Verfasst von Ibrahim Halil Inanc und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Inanc, I. H., Cilingiroglu, M., Ratliff, D., Aksu, C., Inanc, F. A., & Patel, N. (2026). 900.08 Impact Of Active or Prior Cancer on Clinical Outcomes After TAVR: A Real-World Propensity-Matched Analysis. JACC: Cardiovascular Interventions, 19(5), S63-S64. https://doi.org/10.1016/j.jcin.2026.01.218
Vancouver
Inanc IH, Cilingiroglu M, Ratliff D, Aksu C, Inanc FA, Patel N. 900.08 Impact Of Active or Prior Cancer on Clinical Outcomes After TAVR: A Real-World Propensity-Matched Analysis. JACC: Cardiovascular Interventions. 2026;19(5):S63-S64. doi:10.1016/j.jcin.2026.01.218
BibTeX
@article{Inanc2026,
author = {Inanc, Ibrahim Halil and Cilingiroglu, Mehmet and Ratliff, Daniel and Aksu, Cagri and Inanc, Fulden Akyuz and Patel, Nainesh},
title = {900.08 Impact Of Active or Prior Cancer on Clinical Outcomes After TAVR: A Real-World Propensity-Matched Analysis},
journal = {JACC: Cardiovascular Interventions},
year = {2026},
volume = {19},
number = {5},
pages = {S63--S64},
doi = {10.1016/j.jcin.2026.01.218}
}
EUVIMED